Literature DB >> 12952599

B-lymphocytes in bone marrow or lymph nodes can take up plasmid DNA after intramuscular delivery.

Arlete A M Coelho-Castelo1, Rubens R Santos Júnior, Vânia L D Bonato, Maria Célia Jamur, Constance Oliver, Célio Lopes Silva.   

Abstract

Nucleic acid vaccines are an attractive alternative to conventional protein vaccines because of their ability to induce de novo production of antigens in a given tissue after DNA delivery. Although DNA vaccines are highly effective in inducing both cell-mediated and humoral immunity, little is known about the many cell types involved in plasmid DNA uptake in vivo. Here we demonstrate, for the first time, that plasmid DNA can be taken up by both bone marrow and lymph node B cells after intramuscular immunization. Plasmid DNA was also detected in CD11b+ and CD11c+ cells. This phenomenon was not restricted to plasmid DNA encoding mycobacterial 65-kd heat shock protein (pcDNA3-hsp65) because we observed similar results with plasmid-encoding green fluorescent protein (GFP-pEGFP-2C). In addition to plasmid DNA uptake, B cells also express the encoded protein, suggesting that B cells play a role in the immune response after DNA immunization. The biodistribution of plasmid DNA in B cells opens a new perspective in B-cell gene therapy for the in vivo use of plasmid DNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952599     DOI: 10.1089/104303403767740812

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  12 in total

Review 1.  DNA vaccines for prostate cancer.

Authors:  Christopher D Zahm; Viswa Teja Colluru; Douglas G McNeel
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

2.  Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients.

Authors:  Pryscilla Fanini Wowk; Luís Henrique Franco; Denise Morais da Fonseca; Marina Oliveira Paula; Élcio Dos Santos Oliveira Vianna; Ana Paula Wendling; Valéria Maria Augusto; Silvana Maria Elói-Santos; Andréa Teixeira-Carvalho; Flávia Dias Coelho Silva; Solange Alves Vinhas; Olindo Assis Martins-Filho; Moisés Palaci; Célio Lopes Silva; Vânia Luiza Deperon Bonato
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

3.  DNA-hsp65 vaccine as therapeutic strategy to treat experimental chromoblastomycosis caused by Fonsecaea pedrosoi.

Authors:  Isaque Medeiros Siqueira; Alice Melo Ribeiro; Yanna Karla de Medeiros Nóbrega; Karina Smidt Simon; Ana Camila Oliveira Souza; Márcio Souza Jerônimo; Florêncio Figueiredo Cavalcante Neto; Célio Lopes Silva; Maria Sueli Soares Felipe; Anamélia Lorenzetti Bocca
Journal:  Mycopathologia       Date:  2012-11-22       Impact factor: 2.574

4.  B cells Can Modulate the CD8 Memory T Cell after DNA Vaccination Against Experimental Tuberculosis.

Authors:  Luciana P Almeida; Ana Pf Trombone; Julio Cc Lorenzi; Carolina D Rocha; Thiago Malardo; Isabela C Fontoura; Ana F Gembre; Ricardo Ll Silva; Célio L Silva; Ademilson P Castelo; Arlete Am Coelho-Castelo
Journal:  Genet Vaccines Ther       Date:  2011-03-14

5.  Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery.

Authors:  A A M Coelho-Castelo; A P Trombone; R S Rosada; R R Santos; V L D Bonato; A Sartori; C L Silva
Journal:  Genet Vaccines Ther       Date:  2006-01-30

6.  B cells expressing IL-10 mRNA modulate memory T cells after DNA-Hsp65 immunization.

Authors:  I C Fontoura; A P F Trombone; L P Almeida; J C C Lorenzi; R A M Rossetti; T Malardo; E Padilha; W Schluchting; R L L Silva; A F Gembre; J E C Fiuza; C L Silva; A Panunto-Castelo; A A M Coelho-Castelo
Journal:  Braz J Med Biol Res       Date:  2015-09-18       Impact factor: 2.590

7.  A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen.

Authors:  Catherine M Rush; Timothy J Mitchell; Paul Garside
Journal:  Vaccine       Date:  2009-12-23       Impact factor: 3.641

8.  A DNA vaccine against tuberculosis based on the 65 kDa heat-shock protein differentially activates human macrophages and dendritic cells.

Authors:  Luís H Franco; Pryscilla F Wowk; Célio L Silva; Ana P F Trombone; Arlete A M Coelho-Castelo; Constance Oliver; Maria C Jamur; Edson L Moretto; Vânia L D Bonato
Journal:  Genet Vaccines Ther       Date:  2008-01-21

9.  Endocytosis of DNA-Hsp65 alters the pH of the late endosome/lysosome and interferes with antigen presentation.

Authors:  Ana Paula F Trombone; Célio L Silva; Karla M Lima; Constance Oliver; Maria Célia Jamur; Alan R Prescott; Arlete A M Coelho-Castelo
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

10.  Antigen-presenting cells transfected with Hsp65 messenger RNA fail to treat experimental tuberculosis.

Authors:  C D Rocha; A P F Trombone; J C C Lorenzi; L P Almeida; A F Gembre; E Padilha; S G Ramos; C L Silva; A A M Coelho-Castelo
Journal:  Braz J Med Biol Res       Date:  2012-09-18       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.